Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-04
2005-10-04
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S182000
Reexamination Certificate
active
06951858
ABSTRACT:
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:wherein R1, R2, R3a, R3b, R4, R5, and n are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
REFERENCES:
patent: 5780437 (1998-07-01), Goulet et al.
patent: 5849764 (1998-12-01), Goulet et al.
patent: 6673796 (2004-01-01), Pontillo et al.
patent: 748 800 (1996-12-01), None
patent: 48-28026 (1971-08-01), None
patent: WO 96/38438 (1996-12-01), None
patent: WO 97/14682 (1997-04-01), None
patent: WO 97/14697 (1997-04-01), None
patent: WO 97/21435 (1997-06-01), None
patent: WO 97/21703 (1997-06-01), None
patent: WO 97/21704 (1997-06-01), None
patent: WO 97/21707 (1997-06-01), None
patent: WO 97/44037 (1997-11-01), None
patent: WO 97/44041 (1997-11-01), None
patent: WO 97/44321 (1997-11-01), None
patent: WO 97/44339 (1997-11-01), None
patent: WO 98/55116 (1998-12-01), None
patent: WO 98/55119 (1998-12-01), None
patent: WO 98/55470 (1998-12-01), None
patent: WO 98/55479 (1998-12-01), None
patent: WO 99/09033 (1999-02-01), None
patent: WO 99/33831 (1999-07-01), None
patent: WO 00/56739 (2000-09-01), None
patent: WO 00/69859 (2000-11-01), None
patent: WO 01/29044 (2001-04-01), None
Al-Damluji et al., “α1BAdrenergic Receptors in Gonadotrophin-Releasing Hormone Neurones:Relation to Transport-P,”British Journal of Pharmacology132:336-344, 2001.
Burch, “Nitrofuryl Heterocycles. X.1Analogs of 6-(5-Nitro-2-furyl)-as-Triazine-3,5(2H,4H)-dione,”Journal of Medicinal Chemistry13:288-291, 1970.
Cho et al., “Discovery of a Novel, Potent,a nd Orally Active Nonpeptide Antagonist of the Human Luteinizing Hormone-Releasing Hormone (LHRH) Receptor,”J Med Chem. 41(22):4190-4195, Oct. 22, 1998.
Huirne, J. et al., “Gonadotropin-Releasing-Hormone-Receptor Antagonists,”Lancet358(9295):1793-1803, Nov. 2001.
Stanislaus et al., “Regulation of G9/11α by the Gonadotropin-Releasing Hormone Receptor,”Molecular Endocrinology11:738-746, 1997.
Guo Zhiqiang
Pontillo Joseph
Wu Dongpei
Balasubramanian Venkataraman
Neurocrine Biosciences Inc.
Seed IP Law Group PLLC
LandOfFree
Gonadotropin-releasing hormone receptor antagonists and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gonadotropin-releasing hormone receptor antagonists and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gonadotropin-releasing hormone receptor antagonists and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3452769